Ligand Pharmaceuticals Incorporated - Common Stock (NQ:LGND)

302.96 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ligand Pharmaceuticals Incorporated - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Halozyme And Ligand — Two Leading Biotechs — Smash Quarterly Forecasts ↗

August 06, 2024

Halozyme and Ligand beat second-quarter expectations late Tuesday. But only one of the biotech stocks jumped.

Via Investor's Business Daily

Ligand Reports Second Quarter 2024 Financial Results

August 06, 2024

From Ligand Pharmaceuticals Incorporated

Via Business Wire

Assessing Ligand Pharmaceuticals: Insights From 6 Financial Analysts ↗

July 30, 2024

Via Benzinga

Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024

July 23, 2024

From Ligand Pharmaceuticals Incorporated

Via Business Wire

5 Best Short-Term Stocks to Consider Investing In

July 10, 2024

Looking for the best short-term stocks? Explore our top picks and learn how to navigate the risks and opportunities in fast-paced stock trading.

Via MarketBeat

What 4 Analyst Ratings Have To Say About Ligand Pharmaceuticals ↗

June 28, 2024

Via Benzinga

Earnings Scheduled For February 27, 2024 ↗

February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.

Via Benzinga

Ligand to Acquire APEIRON Biologics AG for $100 Million

July 08, 2024

From Ligand Pharmaceuticals Incorporated

Via Business Wire

Lifecore Biomedical Announces Cooperation Agreement with 22NW

July 01, 2024

Provides for the Addition of 22NW Nominees Jason Aryeh and Matthew Korenberg, as Well as Humberto Antunes and Paul Johnson, to the Board

From Lifecore Biomedical, Inc.

Via GlobeNewswire

Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years

June 27, 2024

From Ligand Pharmaceuticals Incorporated

Via Business Wire

Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults

June 18, 2024

From Ligand Pharmaceuticals Incorporated

Via Business Wire

Ligand to Participate in Upcoming Investor Conferences

May 23, 2024

From Ligand Pharmaceuticals Incorporated

Via Business Wire

3 Magnificent Growth Stocks to Buy Hand Over Fist ↗

May 22, 2024

Small-cap stocks could get a boost from the central bank's anticipated rate cuts in 2025. These three stocks may be a great way to get ahead of this catalyst.

Via The Motley Fool

Topics Economy

3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off ↗

May 20, 2024

With the innovation space possibly getting overstretched, these biotech stocks to buy could benefit from a sector rotation.

Via InvestorPlace

LGND Stock Earnings: Ligand Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 ↗

May 07, 2024

LGND stock results show that Ligand Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Ligand Reports First Quarter 2024 Financial Results

May 07, 2024

From Ligand Pharmaceuticals Incorporated

Via Business Wire

Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement

May 07, 2024

From Ligand Pharmaceuticals Incorporated

Via Business Wire

Don't Overlook These Top Medical Stocks As Q1 Earnings Approach ↗

May 07, 2024

While the tech sector has led the Q1 earnings season, investors shouldn’t overlook these top medical stocks. To that point, the growth and expansion of Ligand Pharmaceuticals, Oscar Health, and...

Via Talk Markets

Ligand to Report First Quarter 2024 Financial Results on May 7, 2024

April 23, 2024

From Ligand Pharmaceuticals Incorporated

Via Business Wire

7 Small-Cap Stocks for the Thinking Speculator ↗

April 08, 2024

While these small-cap stocks may be miles away from Wall Street’s spotlight, they’re compelling enough to deliver some big surprises.

Via InvestorPlace

Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference

April 08, 2024

From Ligand Pharmaceuticals Incorporated

Via Business Wire

Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™

April 03, 2024

From Ligand Pharmaceuticals Incorporated

Via Business Wire

Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference

March 05, 2024

From Ligand Pharmaceuticals Incorporated

Via Business Wire

Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 04, 2024

From Ligand Pharmaceuticals Incorporated

Via Business Wire

Why Is Ligand Pharmaceuticals Stock Trading Higher Today? ↗

February 27, 2024

Ligand Pharmaceuticals beats Q4 2023 sales estimates at $28.1 million, with strong core Captisol and royalty figures. CEO Todd Davis highlights transformative 2023 and optimistic guidance for 2024.

Via Benzinga

Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday ↗

February 27, 2024

U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday.

Via Benzinga

Topics Stocks

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 27, 2024

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

Via Benzinga

Ligand Pharmaceuticals Inc. (NASDAQ: LGND) Making Surprising Moves in Tuesday Session

February 27, 2024

Via Investor Brand Network

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 27, 2024

Via Benzinga

Ligand Reports Fourth Quarter and Full Year 2023 Financial Results

February 27, 2024

From Ligand Pharmaceuticals Incorporated

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.